Skip to main content
JIUZHITANG CO.,LTD logo

JIUZHITANG CO.,LTD — Investor Relations & Filings

Ticker · 000989 ISIN · CNE000001394 LEI · 3003004OFW6FCZ34KN72 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,885 across all filing types
Latest filing 2022-08-30 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 000989

About JIUZHITANG CO.,LTD

https://www.hnjzt.com

JIUZHITANG CO.,LTD. is a pharmaceutical enterprise specializing in the research, development, manufacturing, and distribution of Traditional Chinese Medicine (TCM). Established in 1650, the company is recognized as a time-honored brand with a heritage spanning over three centuries. Its core product portfolio includes a diverse range of TCM formulations, most notably Liuwei Dihuang Wan, donkey-hide gelatin (Ejiao), and various health supplements focused on chronic disease management and general wellness. The company operates modern production facilities that integrate traditional processing techniques with contemporary scientific standards and biotechnology. JIUZHITANG focuses on the modernization of TCM through clinical research and innovation, maintaining a distribution network that serves retail pharmacies and medical institutions to provide natural healthcare solutions.

Recent filings

Filing Released Lang Actions
九芝堂股份有限公司独立董事制度
Governance Information Classification · 95% confidence The document is a detailed internal governance policy specifically about the independent director system of a company, including their roles, nomination, election, duties, and protections. It references relevant laws and regulations but does not contain financial data, audit results, or any report of financial performance. It is not an announcement or a brief summary but a governance framework document. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2022-08-30 Chinese
第八届监事会第八次会议监事书面审核意见
Regulatory Filings Classification · 95% confidence The document is a short announcement containing the supervisory board's written review opinion on the company's 2022 semi-annual report. It states that the supervisory board has reviewed and approved the half-year report, confirming its accuracy and compliance. The document length is only 377 characters, indicating it is not the full semi-annual report itself but rather an opinion or certification related to it. According to the rules, such a short document providing a certification or attestation about a report is classified as a Regulatory Filing (RNS), not as the Interim/Quarterly Report (IR) itself.
2022-08-30 Chinese
半年度非经营性资金占用及其他关联资金往来情况汇总表
Interim / Quarterly Report Classification · 95% confidence The document is a detailed financial summary table titled '2022年半年度非经营性资金占用及其他关联资金往来情况汇总表' which translates to '2022 Half-Year Non-Operating Fund Occupation and Other Related Party Fund Transactions Summary'. It contains specific financial data for the half-year period of 2022, including balances, amounts, and interest related to non-operating and related party funds. The presence of substantive financial data for a half-year period indicates this is a financial report for an interim period. The document is not a brief announcement or a certification but a detailed financial summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2022
2022-08-30 Chinese
独立董事关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项说明和独立意见
Regulatory Filings Classification · 95% confidence The document is a special statement and independent opinion by the independent directors of the company regarding related party transactions and external guarantees. It references regulatory rules from the China Securities Regulatory Commission and Shenzhen Stock Exchange, focusing on compliance and risk control related to funds and guarantees. The document is short (598 characters) and does not contain financial statements or detailed financial data. It is not an annual report, audit report, or earnings release. It is a regulatory compliance disclosure related to governance and risk management, fitting best under Regulatory Filings (RNS) as it does not fit other specific categories and is a compliance-related announcement.
2022-08-30 Chinese
九芝堂股份有限公司对外捐赠管理制度
Governance Information Classification · 95% confidence The document is titled as a management system for external donations by the company 九芝堂股份有限公司. It outlines internal policies, principles, procedures, and supervisory responsibilities related to the company's charitable donations. There is no indication that this is a financial report, regulatory filing, or announcement of voting results. It is a governance-related document detailing internal rules and management practices concerning donations. The document length is 2862 characters, which is relatively short but contains substantive policy content rather than a mere announcement. Therefore, the most appropriate classification is Governance Information (CGR).
2022-08-30 Chinese
2022年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "九芝堂股份有限公司2022 年半年度报告全文" which translates to "Jiuzhitang Co., Ltd. 2022 Semi-Annual Report Full Text." It includes detailed financial data, management discussion and analysis, company business overview, financial indicators, and other comprehensive information typical of an interim or quarterly report. The report period is specified as January 1, 2022 to June 30, 2022, confirming it covers a half-year period. The document contains actual financial statements and substantive financial data and analysis, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2022
2022-08-30 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.